No Data
No Data
Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)?
Embecta Corp. (NASDAQ:EMBC), is not the largest company out there, but it saw a double-digit share price rise of over 10% in the past couple of months on the NASDAQGS. The recent rally in share
Embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps With 300u Insulin Reservoir
PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at the American Diabetes
Why Embecta Corp. (NASDAQ:EMBC) Could Be Worth Watching
Embecta CEO Joins the Board at Zimmer Biomet
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdikar, President, Chief...
Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript